Cannabis 'affects babies in womb'
Key points
- Exposure to a cannabis in the womb could cause children to experience learning difficulties and hyperactivity, researchers suggest.
- Each group of rats were given tests to assess their memory and motor activity.
- Researcher Professor Vincenzo Cuomo told BBC News Online: "We cannot say the findings in rats can be directly translated to humans, but we know that animal studies can generate predictive information on various aspects of human brain function."
- Research was carried out on rats using a cannabinoid, a cannabis extract.
Exposure to a cannabis in the womb could cause children to experience learning difficulties and hyperactivity, researchers suggest.
Research was carried out on rats using a cannabinoid, a cannabis extract.
Cannabis is the most widely used drug by women at reproductive age.
Previous research has shown that babies born to mothers who took cannabis while they were pregnant go on to experience problems with physical activity.
In this latest study, researchers injected pregnant rats each day with a quantity of the cannabinoid equivalent to a low to moderate daily dose in humans.
They then compared the baby rats' development with that of a group of rats born to mothers who had not been given the cannabinoid.
The Italian research team said studies on rats could provide more conclusive results than human tests, where findings could be complicated by factors such as impure drugs and cigarette smoking.
Lower scores
"Cannabinoids can be transferred from the mother to the offspring through the placental blood "
Professor Vincenzo Cuomo
Each group of rats were given tests to assess their memory and motor activity.
They were examined as infants (12-days-old), juvenile (40-days-old) and adult (80-days-old).
When the rats were young, those exposed to the cannabinoid were significantly more hyperactive than the other group, though this difference disappeared by adulthood.
But the cannabinoid rats scored lower on learning tests throughout their lives.
The researchers, from the University of Cagliari, Cittadella Universitaria di Monserrato, Italy, used an artificial cannabinoid called WIN in their study.
Post-mortem examinations of the rats brains were carried out.
They found that exposure to WIN in the womb disrupted the release of a neurotransmitter called glutamate which transmits nerve impulses between brain cells.
It also affected a process called long-term potentiation, electrical activity in the brain associated with learning and the formation of memory.
It is believed the effect on glutamate production led to the problems in forming memories in the hippocampus area of the brain.
Consistent
Researcher Professor Vincenzo Cuomo told BBC News Online: "We cannot say the findings in rats can be directly translated to humans, but we know that animal studies can generate predictive information on various aspects of human brain function."
Brain receptors which trigger the behavioural effects of cannabis have been found to be present in rat brains during prenatal development.
Written and revised by
Gerald Hurowitz, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Brain & Nerves →Added benefit of Cannabis sativa for spasticity due to multiple sclerosis is not proven
An extract from the plant Cannabis sativa (trade name Sativex®) was approved in May 2011 for patients suffering from moderate to severe spastic paralysis and muscle spasms due to multiple sclerosis (MS). In an early…
18 September 2012






